Literature DB >> 33623056

High engraftment capacity of frozen ready-to-use human fecal microbiota transplants assessed in germ-free mice.

Magali Berland1, Julie Cadiou2, Florence Levenez3, Nathalie Galleron3, Benoît Quinquis3, Florence Thirion3, Franck Gauthier3, Emmanuelle Le Chatelier3, Florian Plaza Oñate3, Carole Schwintner4, Sylvie Rabot2, Patricia Lepage2, Dusko Ehrlich3, Joël Doré3,2, Catherine Juste3,2.   

Abstract

The number of indications for fecal microbiota transplantation is expected to rise, thus increasing the needs for production of readily available frozen or freeze-dried transplants. Using shotgun metagenomics, we investigated the capacity of two novel human fecal microbiota transplants prepared in maltodextrin-trehalose solutions (abbreviated MD and TR for maltodextrin:trehalose, 3:1, w/w, and trehalose:maltodextrin 3:1, w/w, respectively), to colonize a germ-free born mouse model. Gavage with frozen-thawed MD or TR suspensions gave the taxonomic profiles of mouse feces that best resembled those obtained with the fresh inoculum (Spearman correlations based on relative abundances of metagenomic species around 0.80 and 0.75 for MD and TR respectively), while engraftment capacity of defrosted NaCl transplants most diverged (Spearman correlations around 0.63). Engraftment of members of the family Lachnospiraceae and Ruminoccocaceae was the most challenging in all groups of mice, being improved with MD and TR transplants compared to NaCl, but still lower than with the fresh preparation. Improvement of engraftment of this important group in maintaining health represents a challenge that could benefit from further research on fecal microbiota transplant manufacturing.

Entities:  

Year:  2021        PMID: 33623056     DOI: 10.1038/s41598-021-83638-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  32 in total

Review 1.  Obesity as a medical problem.

Authors:  P G Kopelman
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  The intestinal microflora in allergic Estonian and Swedish 2-year-old children.

Authors:  B Björkstén; P Naaber; E Sepp; M Mikelsaar
Journal:  Clin Exp Allergy       Date:  1999-03       Impact factor: 5.018

3.  Specificities of the fecal microbiota in inflammatory bowel disease.

Authors:  Harry Sokol; Philippe Seksik; Lionel Rigottier-Gois; Christophe Lay; Patricia Lepage; Isabelle Podglajen; Philippe Marteau; Joël Doré
Journal:  Inflamm Bowel Dis       Date:  2006-02       Impact factor: 5.325

Review 4.  Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

Authors:  Christina M Surawicz; Lawrence J Brandt; David G Binion; Ashwin N Ananthakrishnan; Scott R Curry; Peter H Gilligan; Lynne V McFarland; Mark Mellow; Brian S Zuckerbraun
Journal:  Am J Gastroenterol       Date:  2013-02-26       Impact factor: 10.864

5.  Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation.

Authors:  Min-Soo Kim; Seong-Soo Hwang; Eun-Jin Park; Jin-Woo Bae
Journal:  Environ Microbiol Rep       Date:  2013-07-19       Impact factor: 3.541

Review 6.  The Human Microbiome and Obesity: Moving beyond Associations.

Authors:  Padma Maruvada; Vanessa Leone; Lee M Kaplan; Eugene B Chang
Journal:  Cell Host Microbe       Date:  2017-11-08       Impact factor: 21.023

7.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

8.  Microbial dysbiosis in colorectal cancer (CRC) patients.

Authors:  Iradj Sobhani; Julien Tap; Françoise Roudot-Thoraval; Jean P Roperch; Sophie Letulle; Philippe Langella; Gérard Corthier; Jeanne Tran Van Nhieu; Jean P Furet
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

9.  European consensus conference on faecal microbiota transplantation in clinical practice.

Authors:  Giovanni Cammarota; Gianluca Ianiro; Herbert Tilg; Mirjana Rajilić-Stojanović; Patrizia Kump; Reetta Satokari; Harry Sokol; Perttu Arkkila; Cristina Pintus; Ailsa Hart; Jonathan Segal; Marina Aloi; Luca Masucci; Antonio Molinaro; Franco Scaldaferri; Giovanni Gasbarrini; Antonio Lopez-Sanroman; Alexander Link; Pieter de Groot; Willem M de Vos; Christoph Högenauer; Peter Malfertheiner; Eero Mattila; Tomica Milosavljević; Max Nieuwdorp; Maurizio Sanguinetti; Magnus Simren; Antonio Gasbarrini
Journal:  Gut       Date:  2017-01-13       Impact factor: 23.059

10.  Bacterial protein signals are associated with Crohn's disease.

Authors:  Catherine Juste; David P Kreil; Christian Beauvallet; Alain Guillot; Sebastian Vaca; Christine Carapito; Stanislas Mondot; Peter Sykacek; Harry Sokol; Florence Blon; Pascale Lepercq; Florence Levenez; Benoît Valot; Wilfrid Carré; Valentin Loux; Nicolas Pons; Olivier David; Brigitte Schaeffer; Patricia Lepage; Patrice Martin; Véronique Monnet; Philippe Seksik; Laurent Beaugerie; S Dusko Ehrlich; Jean-François Gibrat; Alain Van Dorsselaer; Joël Doré
Journal:  Gut       Date:  2014-01-16       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.